Amnavero.
← Research directory

Research profile

AOD-9604

AOD-9604 is a modified fragment of human growth hormone that was studied for effects on fat metabolism and body weight.

  • Human obesity trial reviewed
  • Evaluation only
Amnavero AOD-9604 research vial concept packaging
Amnavero AOD-9604
Concept packaging

What the research found

In a 24-week oral obesity trial summarized by FDA, weight loss with AOD-9604 did not differ significantly from placebo.

What remains uncertain

The reviewed trial did not establish a weight-loss benefit. Evidence on other formulations and long-term safety remains limited.